
NNBR, EQNR and IMAX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 12, 2026.
IMAX Corporation, is a worldwide entertainment technology company. The company is headquartered in Mississauga, Canada.
| Revenue (TTM) | $416.08M |
| Gross Profit (TTM) | $248.52M |
| EBITDA | $138.22M |
| Operating Margin | 22.50% |
| Return on Equity | 11.00% |
| Return on Assets | 6.65% |
| Revenue/Share (TTM) | $7.68 |
| Book Value | $6.49 |
| Price-to-Book | 8.26 |
| Price-to-Sales (TTM) | 6.70 |
| EV/Revenue | 7.36 |
| EV/EBITDA | 23.13 |
| Quarterly Earnings Growth (YoY) | 35.00% |
| Quarterly Revenue Growth (YoY) | 12.20% |
| Shares Outstanding | $54.84M |
| Float | $41.89M |
| % Insiders | 17.93% |
| % Institutions | 99.05% |
Volatility is currently expanding

NNBR, EQNR and IMAX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 12, 2026.

EQNR, NNBR, IMAX, MCY and ROST have been added to the Zacks Rank #1 (Strong Buy) List on October 12, 2026.

IMAX Corp (NYSE:IMAX)'s position looks secure for now, according to Wedbush, which poured water on a Bloomberg report that Disney has pushed to build a competing premium screen network. According to Bloomberg, Disney has approached Skydance/Paramount Studios and Universal about forming a coalition to rival IMAX screens.

Top-ranked stocks ELF, IMAX, CBRL, FTNT and VLO are likely to beat on the bottom line in their upcoming releases.

Institutions have bought IMAX Corporation (IMAX) shares in huge ways – 47 outlier inflows since 2010.

IMAX Corporation is rated a Strong Buy, driven by record-breaking summer box office results and a unique, high-margin business model. IMAX's technology licensing, premium brand, and system sales position it to benefit from blockbuster films designed specifically for its format. The Odyssey's IMAX-exclusive production and performance signal a structural shift toward premium theatrical experiences, boosting IMAX's growth runway.

IMAX Corporation remains a Buy based on my assessment of the company's outlook after the launch of The Odyssey movie. FY2026 guidance targets a 52% worldwide box office increase and 5.6ppts EBITDA margin expansion versus the FY2024 baseline, underpinned by a more favorable mix and additional merchandising revenues. IMAX's EPS CAGR is expected to go from FY16–25's +7.9% to +19.5% for FY25-29, as the brand becomes increasingly favored by various stakeholders in the film industry.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Morgan Stanley initiated coverage on IMAX NYSE: IMAX on Sept. 24 at Overweight with a $63 price target.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on IMAX and any ticker you trade — then tracks every position and per-strategy win rate.